Meropenem how supplied: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 2: | Line 2: | ||
{{Meropenem}} | {{Meropenem}} | ||
{{CMG}} | {{CMG}} | ||
== | ==How Supplied== | ||
MERREM I.V. is supplied in 20 mL and 30 mL injection vials containing sufficient meropenem to deliver 500 mg or 1 g for intravenous administration, | MERREM I.V. is supplied in 20 mL and 30 mL injection vials containing sufficient meropenem to deliver 500 mg or 1 g for intravenous administration, | ||
respectively. The dry powder should be stored at controlled room temperature 20-25ºC (68-77ºF) [see USP]. | respectively. The dry powder should be stored at controlled room temperature 20-25ºC (68-77ºF) [see USP]. | ||
Revision as of 01:36, 23 December 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
How Supplied
MERREM I.V. is supplied in 20 mL and 30 mL injection vials containing sufficient meropenem to deliver 500 mg or 1 g for intravenous administration, respectively. The dry powder should be stored at controlled room temperature 20-25ºC (68-77ºF) [see USP].
500 mg Injection Vial (NDC 0310-0325-20)
1 g Injection Vial (NDC 0310-0321-30)[1]
References
- ↑ "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050706s022lbl.pdf" (PDF). External link in
|title=(help)
Adapted from the FDA Package Insert.